These findings were also validated in another BRCA2-mutated ovarian cancer cell line Kuramochi (Supplementary Fig. 2A, B), indicating that Polθ plays a central role in ALDH1A1-mediated olaparib resistance. This evidence concerns the gene ALDH1A1 and ovarian carcinoma.